Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity

International Journal of Biochemistry and Cell Biology

Volumn 44, Issue 5, 2012, Pages 738-747

  Busek, Petr ^a   Stremenova, Jarmila ^a   Sromova, Lucie ^a   Hilser, Marek ^a   Balaziova, Eva ^a   Kosek, Dalibor ^a   Trylcova, Jana ^a   Strnad, Hynek ^b   Krepela, Evzen ^a   Sedo, Aleksi ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

Astrocytoma; Primary cell cultures; Protease; Tumor suppression

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL ACTIVATION; CELL ADHESION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FIBROBLAST; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; IMMUNOMAGNETIC SEPARATION; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; TUMOR CELL; XENOTRANSPLANTATION;

ANIMALS; CELL ADHESION; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; DIPEPTIDASES; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOMAGNETIC SEPARATION; MALE; MICE; MUTATION; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84859264963     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.01.011     Document Type: Article

References (61)

1. W.T. Arscott, A.E. LaBauve, V. May, and U.V. Wesley Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation Oncogene 28 2009 479 491
2. A. Bajetto, F. Barbieri, A. Dorcaratto, S. Barbero, A. Daga, and C. Porcile Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration Neurochem Int 49 2006 423 432 (Pubitemid 44189638)
3. E. Balaziova, P. Busek, J. Stremenova, L. Sromova, E. Krepela, and L. Lizcova Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-α in transformed astrocytic cells Mol Cell Biochem 354 2011 283 289
4. U. Bank, A. Heimburg, A. Wohlfarth, G. Koch, K. Nordhoff, and H. Julius Outside or inside: role of the subcellular localization of DP4-like enzymes for substrate conversion and inhibitor effects Biol Chem 392 2011 169 187
5. P. Busek, E. Krepela, V. Mares, K. Vlasicova, J. Sevcik, and A. Sedo Expression and function of dipeptidyl peptidase IV and related enzymes in cancer Adv Exp Med Biol 575 2006 55 62
6. P. Busek, R. Malik, and A. Sedo Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer Int J Biochem Cell Biol 36 2004 408 421 (Pubitemid 37542440)
7. P. Busek, J. Stremenova, E. Krepela, and A. Sedo Modulation of substance P signaling by dipeptidyl peptidase-IV enzymatic activity in human glioma cell lines Physiol Res 57 2008 443 449
8. N.A. Charles, E.C. Holland, R. Gilbertson, R. Glass, and H. Kettenmann The brain tumor microenvironment Glia 59 2011 1169 1180
9. H.C. Cheng, M. Abdel-Ghany, and B.U. Pauli A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis J Biol Chem 278 2003 24600 24607 (Pubitemid 37548613)
10. S.R. Chirasani, A. Sternjak, P. Wend, S. Momma, B. Campos, and I.M. Herrmann Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells Brain 133 2010 1961 1972
11. D.T. Dang, S.Y. Chun, K. Burkitt, M. Abe, S. Chen, and P. Havre Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition Cancer Res 68 2008 1872 1880 (Pubitemid 351416573)
12. H. Dolznig, N. Schweifer, C. Puri, N. Kraut, W.J. Rettig, and D. Kerjaschki Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin Cancer Immun 5 2005 10
13. C. Durinx, A.M. Lambeir, E. Bosmans, J.B. Falmagne, R. Berghmans, and A. Haemers Molecular characterization of dipeptidyl peptidase activity in serum - soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides Eur J Biochem 267 2000 5608 5613
14. G. Foltz, G.Y. Ryu, J.G. Yoon, T. Nelson, J. Fahey, and A. Frakes Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma Cancer Res 66 2006 6665 6674 (Pubitemid 44085623)
15. G. Ghersi, W. Chen, E.W. Lee, and Z. Zukowska Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding Peptides 22 2001 453 458 (Pubitemid 32250247)
16. M. Gonzalez-Gronow, S. Kaczowka, G. Gawdi, and S.V. Pizzo Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor Front Biosci 13 2008 1610 1618 (Pubitemid 351599720)
17. K. Hirai, T. Kotani, Y. Aratake, S. Ohtaki, and K. Kuma Dipeptidyl peptidase IV (DPP IV/CD26) staining predicts distant metastasis of 'benign' thyroid tumor Pathol Int 49 1999 264 265 (Pubitemid 29210557)
18. D.B. Hoelzinger, T. Demuth, and M.E. Berens Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment J Natl Cancer Inst 99 2007 1583 1593 (Pubitemid 351767231)
19. D.W. Huang, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat Protoc 4 2009 44 57
20. T. Inamoto, T. Yamada, K. Ohnuma, S. Kina, N. Takahashi, and T. Yamochi Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors Clin Cancer Res 13 2007 4191 4200 (Pubitemid 47105983)
21. T. Inamoto, T. Yamochi, K. Ohnuma, S. Iwata, S. Kina, and S. Inamoto Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix Clin Cancer Res 12 2006 3470 3477
22. J.E. Jahn, D.H. Best, and W.B. Coleman Exogenous expression of synaptotagmin XIII suppresses the neoplastic phenotype of a rat liver tumor cell line through molecular pathways related to mesenchymal to epithelial transition Exp Mol Pathol 89 2010 209 216
23. H. Kajiyama, F. Kikkawa, E. Khin, K. Shibata, K. Ino, and S. Mizutani Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells Cancer Res 63 2003 2278 2283 (Pubitemid 36538637)
24. H. Kajiyama, F. Kikkawa, T. Suzuki, K. Shibata, K. Ino, and S. Mizutani Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma Cancer Res 62 2002 2753 2757 (Pubitemid 34525756)
25. K. Kessenbrock, V. Plaks, and Z. Werb Matrix metalloproteinases: regulators of the tumor microenvironment Cell 141 2010 52 67
26. N. Levicar, R.K. Nuttall, and T.T. Lah Proteases in brain tumour progression Acta Neurochir 145 2003 825 838 (Pubitemid 37204559)
27. Z. Liu, M. Christensson, A. Forslow, I. De Meester, and K.G. Sundqvist A CD26-controlled cell surface cascade for regulation of T cell motility and chemokine signals J Immunol 183 2009 3616 3624
28. Z. Lojda Proteinases in pathology. Usefulness of histochemical methods J Histochem Cytochem 29 1981 481 493 (Pubitemid 11121535)
29. C. Lopez-Otin, and L.M. Matrisian Emerging roles of proteases in tumour suppression Nat Rev Cancer 7 2007 800 808 (Pubitemid 47463671)
30. K. Loster, K. Zeilinger, D. Schuppan, and W. Reutter The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site Biochem Biophys Res Commun 217 1995 341 348
31. D.N. Louis, S.L. Pomeroy, and J.G. Cairncross Focus on central nervous system neoplasia Cancer Cell 1 2002 125 128 (Pubitemid 41039158)
32. D.S. Markovic, K. Vinnakota, S. Chirasani, M. Synowitz, H. Raguet, and K. Stock Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion Proc Natl Acad Sci USA 106 2009 12530 12535
33. T. Mashima, S. Sato, Y. Sugimoto, T. Tsuruo, and H. Seimiya Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions Oncogene 28 2009 9 19
34. T.M. Mayhew, and D.R. Olsen Magnetic resonance imaging (MRI) and model-free estimates of brain volume determined using the Cavalieri principle J Anat 178 1991 133 144
35. C.H. McIntosh Dipeptidyl peptidase IV inhibitors and diabetes therapy Front Biosci 13 2008 1753 1773 (Pubitemid 351599730)
36. R. Mentlein Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides Regul Peptides 85 1999 9 24 (Pubitemid 29505281)
37. R. Mentlein, K. Hattermann, C. Hemion, A. Jungbluth, and J. Held-Feindt Expression and role of the cell surface protease seprase/fibroblast activation protein-alpha (FAP-alpha) in astroglial tumors Biol Chem 392 2011 199 207
38. J.J. Neumiller, L. Wood, and R.K. Campbell Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus Pharmacotherapy 30 2010 463 484
39. K. Ohnuma, N. Takahashi, T. Yamochi, O. Hosono, N.H. Dang, and C. Morimoto Role of CD26/dipeptidyl peptidase IV in human T cell activation and function Front Biosci 13 2008 2299 2310 (Pubitemid 351589255)
40. C. Palma, and C.A. Maggi The role of tachykinins via NK1 receptors in progression of human gliomas Life Sci 67 2000 985 1001 (Pubitemid 30485803)
41. R. Pang, W.L. Law, A.C. Chu, J.T. Poon, C.S. Lam, and A.K. Chow A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer Cell Stem Cell 6 2010 603 615
42. K.I. Patterson, T. Brummer, R.J. Daly, and P.M. O'Brien DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs Biochim Biophys Acta 1803 2010 1003 1012
43. C.L. Pethiyagoda, D.R. Welch, and T.P. Fleming Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells Clin Exp Metastasis 18 2000 391 400 (Pubitemid 32588619)
44. J. Pinski, G. Halmos, Y. Shirahige, J.L. Wittliff, and A.V. Schally Inhibition of growth of the human malignant glioma cell line (U87MG) by the steroid hormone antagonist RU486 J Clin Endocrinol Metab 77 1993 1388 1392 (Pubitemid 23345502)
45. J.S. Rao Molecular mechanisms of glioma invasiveness: the role of proteases Nat Rev Cancer 3 2003 489 501 (Pubitemid 37328837)
46. T. Sato, T. Yamochi, T. Yamochi, U. Aytac, K. Ohnuma, and K.S. McKee CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299 Cancer Res 65 2005 6950 6956 (Pubitemid 41060735)
47. A. Sedo, P. Busek, E. Scholzova, R. Malik, K. Vlasicova, and S. Janackova 'Dipeptidyl peptidase-IV activity and/or structure homologs' (DASH) in growth-modulated glioma cell lines Biol Chem 385 2004 557 559 (Pubitemid 38967786)
48. A. Sedo, E. Krepela, and E. Kasafirek A kinetic fluorometric assay of dipeptidyl peptidase IV in viable human blood mononuclear cells Biochimie 71 1989 757 761 (Pubitemid 19166382)
49. A. Sedo, and R. Malik Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities? Biochim Biophys Acta 1550 2001 107 116 (Pubitemid 34037997)
50. A. Sedo, J. Stremenova, P. Busek, and J.S. Duke-Cohan Dipeptidyl peptidase-IV and related molecules: markers of malignancy? Exp Opin Med Diagn 2 2008 677 689 (Pubitemid 351997856)
51. J. Stremenova, E. Krepela, V. Mares, J. Trim, V. Dbaly, and J. Marek Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade Int J Oncol 31 2007 785 792
52. Y.X. Sun, E.A. Pedersen, Y. Shiozawa, A.M. Havens, Y. Jung, and J. Wang CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12 Clin Exp Metastasis 25 2008 765 776
53. The Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 2008 1061 1068
54. Y. Tu, W. Wu, T. Wu, Z. Cao, R. Wilkins, and B.H. Toh Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways J Biol Chem 282 2007 11722 11731 (Pubitemid 47100724)
55. P.Y. Wen, and S. Kesari Malignant gliomas in adults N Engl J Med 359 2008 492 507
56. U.V. Wesley, A.P. Albino, S. Tiwari, and A.N. Houghton A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells J Exp Med 190 1999 311 322 (Pubitemid 29374829)
57. U.V. Wesley, M. McGroarty, and A. Homoyouni Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway Cancer Res 65 2005 1325 1334 (Pubitemid 40270159)
58. U.V. Wesley, S. Tiwari, and A.N. Houghton Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells Int J Cancer 109 2004 855 866 (Pubitemid 38500742)
59. U. Yamaguchi, R. Nakayama, K. Honda, H. Ichikawa, T. Hasegawa, and M. Shitashige Distinct gene expression-defined classes of gastrointestinal stromal tumor J Clin Oncol 26 2008 4100 4108
60. D.M. Yu, T.W. Yao, S. Chowdhury, N.A. Nadvi, B. Osborne, and W.B. Church The dipeptidyl peptidase IV family in cancer and cell biology FEBS J 277 2010 1126 1144
61. H. Zheng, L. Gao, Y. Feng, L. Yuan, H. Zhao, and L.A. Cornelius Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration Cancer Res 69 2009 449 457